CPC A61K 31/167 (2013.01) [A61K 31/4365 (2013.01); A61K 31/616 (2013.01); A61K 31/7064 (2013.01); A61K 31/727 (2013.01); A61K 38/482 (2013.01); A61P 7/02 (2018.01)] | 3 Claims |
1. A method of reducing a risk of, inhibiting, reducing, or mitigating coronavirus-induced vascular instability in a subject, comprising administering to the subject a therapeutically effective amount of a compound having the structure of Formula IV:
or a pharmaceutically acceptable salt, stereoisomer or tautomer thereof.
|